Interpace Biosciences, Inc. ã¯ãç±³åœã§ãããªã¹ã¯ãè©äŸ¡ããããã®ååèšºææ€æ»ããã€ãªã€ã³ãã©ããã£ã¯ã¹ãç
çåŠãµãŒãã¹ãæäŸããŠããŸããå瀟ã¯ãèµèå¢èããã³èµè管åºåœ¢ç
å€ã®ã²ãã æ€æ» PancraGEN ãæäŸããŠããŸãããã®æ€æ»ã¯ãPathFinderTG ãã©ãããã©ãŒã ã䜿çšããŠå»åž«ãèµè管ããã®ãªã¹ã¯ãããé©åã«è©äŸ¡ããã®ã«åœ¹ç«ã¡ãŸãããŸããæªæ§ç²ç¶è
ºçµç¯ãèå¥ããããã®çºããæ§å€ç°ããã« ThyGeNEXT ãæäŸããŠããŸãããŸããç¬èªã®ãã€ã¯ã RNA éºäŒåçºçŸã¢ãã»ã€ã䜿çšããŠç²ç¶è
ºçµç¯ã®æªæ§ãªã¹ã¯ãè©äŸ¡ãã ThyraMIR ãã転移æ§ãŸãã¯åçºæ§èºãããåºå¥ããã®ã«åœ¹ç«ã€ã²ãã æ€æ» RespriDx ãæäŸããŠããŸããå瀟ã¯ãŸããè£œè¬æ¥çããã³ãã€ãªãã¯ãããžãŒæ¥çåãã«ãè¬çã²ãã æ€æ»ãéºäŒååå€å®ããã€ãªã¬ããžããªããã®ä»ã®ã«ã¹ã¿ãã€ãºããããµãŒãã¹ãæäŸããŠããŸããäž»ã«å»åž«ãç
é¢ã蚺çæã«ãµãŒãã¹ãæäŸããŠããŸããå瀟ã¯ä»¥åã¯Interpace Diagnostics Group, Inc.ãšããŠç¥ãããŠããŸãããã2019幎11æã«Interpace Biosciences, Inc.ã«ç€Ÿåã倿ŽããŸãããInterpace Biosciences, Inc.ã¯1986幎ã«èšç«ããããã¥ãŒãžã£ãŒãžãŒå·ããŒã·ããããŒã«æ¬ç€Ÿã眮ããŠããŸãã